Photocure signs agreement with Salix Pharmaceuticals for Lumacan
21-Oct-2010 -
Photocure announced it has signed a strategic global agreement with Salix Pharmaceuticals Inc. for the development and commercialisation of Lumacan. Lumacan is a photodynamic colorectal diagnostic intended to significantly improve the detection of precancerous and cancerous lesions in the colon ...
colon cancer
colorectal cancer
fluorescence
+1